PL2961775T3 - Kompozycje farmaceutyczne o zwiększonej skuteczności i ulepszonej przetwarzalności - Google Patents
Kompozycje farmaceutyczne o zwiększonej skuteczności i ulepszonej przetwarzalnościInfo
- Publication number
- PL2961775T3 PL2961775T3 PL14708748T PL14708748T PL2961775T3 PL 2961775 T3 PL2961775 T3 PL 2961775T3 PL 14708748 T PL14708748 T PL 14708748T PL 14708748 T PL14708748 T PL 14708748T PL 2961775 T3 PL2961775 T3 PL 2961775T3
- Authority
- PL
- Poland
- Prior art keywords
- pharmaceutical compositions
- enhanced performance
- improved processability
- processability
- improved
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B13/00—Preparation of cellulose ether-esters
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L1/00—Compositions of cellulose, modified cellulose or cellulose derivatives
- C08L1/08—Cellulose derivatives
- C08L1/32—Cellulose ether-esters
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Polymers & Plastics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Materials Engineering (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361771291P | 2013-03-01 | 2013-03-01 | |
| PCT/US2014/017585 WO2014133885A1 (en) | 2013-03-01 | 2014-02-21 | Pharmaceutical compositions with enhanced performance and improved processability |
| EP14708748.0A EP2961775B1 (en) | 2013-03-01 | 2014-02-21 | Pharmaceutical compositions with enhanced performance and improved processability |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2961775T3 true PL2961775T3 (pl) | 2020-11-16 |
Family
ID=50238485
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL14708748T PL2961775T3 (pl) | 2013-03-01 | 2014-02-21 | Kompozycje farmaceutyczne o zwiększonej skuteczności i ulepszonej przetwarzalności |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US9492550B2 (pl) |
| EP (1) | EP2961775B1 (pl) |
| JP (1) | JP6456849B2 (pl) |
| KR (1) | KR102209479B1 (pl) |
| CN (1) | CN105073783B (pl) |
| BR (1) | BR112015021179B1 (pl) |
| CA (1) | CA2899546C (pl) |
| MX (1) | MX363722B (pl) |
| PL (1) | PL2961775T3 (pl) |
| RU (1) | RU2656662C2 (pl) |
| WO (1) | WO2014133885A1 (pl) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6456849B2 (ja) * | 2013-03-01 | 2019-01-23 | ハーキュリーズ・インコーポレーテッドＨｅｒｃｕｌｅｓ Ｉｎｃｏｒｐｏｒａｔｅｄ | 高められた性能及び改善された加工性を有する医薬組成物 |
| WO2015126576A1 (en) * | 2014-02-20 | 2015-08-27 | Dow Global Technologies Llc | Novel esterified cellulose ethers of high molecular weight and homogeneity |
| WO2015200054A2 (en) | 2014-06-24 | 2015-12-30 | The Trustees Of Princeton University | Process for encapsulating soluble biologics, therapeutics, and imaging agents |
| CN107567462B (zh) * | 2015-05-15 | 2020-10-16 | 陶氏环球技术有限责任公司 | 用于制造具有极高分子量和低粘度的酯化纤维素醚的方法 |
| JP6737810B2 (ja) * | 2015-05-15 | 2020-08-12 | ダウ グローバル テクノロジーズ エルエルシー | 高分子量のエステル化セルロースエーテルを調製するプロセス |
| WO2017112828A1 (en) | 2015-12-22 | 2017-06-29 | The Trustees Of Princeton University | Process for encapsulating soluble biologics, therapeutics, and imaging agents |
| US9884922B2 (en) * | 2016-03-11 | 2018-02-06 | Shin-Etsu Chemical Co., Ltd. | Hypromellose acetate succinate, method for producing the same and composition containing the same |
| JP2019531390A (ja) * | 2016-10-18 | 2019-10-31 | ダウ グローバル テクノロジーズ エルエルシー | エステル化セルロースエーテルを調製する効率的な方法 |
| WO2019055539A1 (en) | 2017-09-12 | 2019-03-21 | Prudhomme Robert K | CELLULOSIC POLYMER NANOPARTICLES AND METHODS OF FORMING THE SAME |
| JP2021501753A (ja) | 2017-11-03 | 2021-01-21 | ザ・トラスティーズ・オブ・プリンストン・ユニバーシティＴｈｅ Ｔｒｕｓｔｅｅｓ Ｏｆ Ｐｒｉｎｃｅｔｏｎ Ｕｎｉｖｅｒｓｉｔｙ | 徐放性ナノキャリア製剤を形成するための疎水性イオン対化およびフラッシュナノ沈殿 |
| WO2020018890A1 (en) | 2018-07-19 | 2020-01-23 | Prudhomme Robert K | Triblock copolymer stabilizers for the formation of nanoparticles encapsulating soluble biologics, therapeutics, and imaging agents |
| US11731099B2 (en) | 2018-07-20 | 2023-08-22 | The Trustees Of Princeton University | Method for controlling encapsulation efficiency and burst release of water soluble molecules from nanoparticles and microparticles produced by inverse flash nanoprecipitation |
| WO2020099937A2 (en) * | 2018-11-14 | 2020-05-22 | Prud'homme, Robert, K. | Dihydromyricetin spray-dried dispersion formulations and methods for forming them |
| US20200147032A1 (en) | 2018-11-14 | 2020-05-14 | Robert K. Prud'homme | Dihydromyricetin hot melt extrusion formulations and methods for forming them |
| MX2021015457A (es) | 2019-06-14 | 2022-04-06 | Univ Princeton | Formulaciones de dihidromiricetina y un permeabilizante. |
| CN117774069B (zh) * | 2023-12-08 | 2026-05-26 | 广东海洋大学 | 自动送料富贵竹切枝装置及富贵竹切枝方法 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4226981A (en) | 1977-09-28 | 1980-10-07 | Shin-Etsu Chemical Co., Ltd. | Ether-ester derivatives of cellulose and their applications |
| JPS5535031A (en) | 1978-09-04 | 1980-03-11 | Shin Etsu Chem Co Ltd | Enteric coating composition |
| JPS6281402A (ja) * | 1985-10-07 | 1987-04-14 | Shin Etsu Chem Co Ltd | セルロ−スエ−テル酸性ジカルボン酸エステルの製造方法 |
| JP3149122B2 (ja) * | 1994-11-07 | 2001-03-26 | 信越化学工業株式会社 | 固形腸溶製剤のコーティング用基剤 |
| PT901786E (pt) | 1997-08-11 | 2007-08-07 | Pfizer Prod Inc | Disperções farmacêuticas sólidas com biodisponibilidade melhorada |
| EP1027885B1 (en) | 1999-02-09 | 2008-07-09 | Pfizer Products Inc. | Basic drug compositions with enhanced bioavailability |
| YU43702A (sh) | 1999-12-23 | 2004-11-25 | Pfizer Products Inc. | Farmaceutske kompozicije koje obezbeđuju povećanje koncentracije leka |
| US20050013835A1 (en) * | 2003-07-15 | 2005-01-20 | Pfizer Inc. | Stable non-dihydrate azithromycin oral suspensions |
| EP1753402B1 (en) | 2004-05-28 | 2008-10-01 | Pfizer Products Incorporated | Pharmaceutical compositions with enhanced performance comprising a hpmca polymer |
| US20060159753A1 (en) * | 2004-12-27 | 2006-07-20 | Eisai Co. Ltd. | Matrix type sustained-release preparation containing basic drug or salt thereof |
| EP2000152A4 (en) | 2006-03-23 | 2013-01-23 | Shionogi & Co | SOLID PREPARATION WITH IMPROVED SOLUBILITY |
| JP2010526848A (ja) | 2007-05-11 | 2010-08-05 | エフ．ホフマン−ラ ロシュ アーゲー | 難溶性薬物用の医薬組成物 |
| WO2011159626A1 (en) * | 2010-06-14 | 2011-12-22 | Bend Research, Inc. | Hydroxypropyl methyl cellulose acetate succinate with enhanced acetate and succinate substitution |
| US9453081B2 (en) | 2012-03-27 | 2016-09-27 | Dow Global Technologies Llc | Process of preparing an ester of a cellulose ether |
| US9320799B2 (en) | 2012-04-11 | 2016-04-26 | Dow Global Technologies Llc | Esterified cellulose ethers having a specific substituent distribution |
| JP6456849B2 (ja) * | 2013-03-01 | 2019-01-23 | ハーキュリーズ・インコーポレーテッドＨｅｒｃｕｌｅｓ Ｉｎｃｏｒｐｏｒａｔｅｄ | 高められた性能及び改善された加工性を有する医薬組成物 |
-
2014
- 2014-02-21 JP JP2015560226A patent/JP6456849B2/ja active Active
- 2014-02-21 WO PCT/US2014/017585 patent/WO2014133885A1/en not_active Ceased
- 2014-02-21 KR KR1020157023293A patent/KR102209479B1/ko active Active
- 2014-02-21 RU RU2015141521A patent/RU2656662C2/ru active
- 2014-02-21 EP EP14708748.0A patent/EP2961775B1/en active Active
- 2014-02-21 CA CA2899546A patent/CA2899546C/en active Active
- 2014-02-21 MX MX2015010398A patent/MX363722B/es active IP Right Grant
- 2014-02-21 CN CN201480011462.1A patent/CN105073783B/zh active Active
- 2014-02-21 PL PL14708748T patent/PL2961775T3/pl unknown
- 2014-02-21 US US14/186,147 patent/US9492550B2/en active Active
- 2014-02-21 BR BR112015021179-8A patent/BR112015021179B1/pt active IP Right Grant
-
2016
- 2016-07-22 US US15/216,936 patent/US10106625B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| RU2015141521A (ru) | 2017-04-06 |
| EP2961775A1 (en) | 2016-01-06 |
| US20140249235A1 (en) | 2014-09-04 |
| JP6456849B2 (ja) | 2019-01-23 |
| US20160376380A1 (en) | 2016-12-29 |
| WO2014133885A1 (en) | 2014-09-04 |
| CA2899546C (en) | 2017-10-10 |
| JP2016510080A (ja) | 2016-04-04 |
| US9492550B2 (en) | 2016-11-15 |
| MX2015010398A (es) | 2015-10-29 |
| KR102209479B1 (ko) | 2021-02-01 |
| CN105073783A (zh) | 2015-11-18 |
| CN105073783B (zh) | 2018-04-03 |
| BR112015021179A2 (pt) | 2017-07-18 |
| EP2961775B1 (en) | 2020-04-08 |
| RU2656662C2 (ru) | 2018-06-06 |
| US10106625B2 (en) | 2018-10-23 |
| MX363722B (es) | 2019-03-29 |
| CA2899546A1 (en) | 2014-09-04 |
| BR112015021179B1 (pt) | 2021-11-30 |
| KR20150125655A (ko) | 2015-11-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL273205A (en) | Preparations and methods | |
| IL244850B (en) | Stabilized epinaconazole preparations, and their uses | |
| IL244877A0 (en) | Compounds and composites for high performance | |
| GB2521022B (en) | Compositions and methods | |
| GB2518288B (en) | Fuel compositions | |
| GB2535911B (en) | Strigolactone formulations and uses thereof | |
| IL245504B (en) | Compositions comprising dextromethorphan or related compounds and uses thereof | |
| EP2989240A4 (en) | INTERLEUKIN-10 COMPOSITIONS AND USES THEREOF | |
| ZA201604585B (en) | Multistage polymers and compositions thereof | |
| SMT201900339T1 (it) | Coniugati anticorpo anti-dll3/pbd e loro usi | |
| ZA201505966B (en) | Peptides and compositions | |
| IL240982B (en) | mrna cftr compositions related methods and uses | |
| GB201308072D0 (en) | Compositions and methods | |
| GB201321693D0 (en) | Composition and uses thereof | |
| SG11201508167PA (en) | Therapeutic compositions and uses thereof | |
| EP2992334A4 (en) | Novel phosphatidylalkanols and compositions thereof | |
| IL276126B (en) | Preparations containing l-4-chloroquinonerine and their uses | |
| EP2968620A4 (en) | POLYMERIC COMPOSITIONS HAVING ENHANCED RADIO-OPACITY | |
| EP3007720A4 (en) | COMPOSITION COMPRISING THE GC MACROPHAGE ACTIVATION FACTOR AND USES THEREOF | |
| GB201305813D0 (en) | Compositions and methods | |
| EP2964610A4 (en) | VINYL SULFON-BASED 18F LABELING COMPOSITIONS AND METHOD AND USES THEREOF | |
| TWI562776B (en) | Pharmaceutical composition and uses thereof | |
| ZA201601880B (en) | Hetero-transglycosylase and uses thereof | |
| GB201308242D0 (en) | Compositions and uses thereof | |
| GB201301022D0 (en) | Composition and uses thereof |